Home h/c testing co grabs $2.5m
This article was originally published in Clinica
BioIQ is looking to expand its product portfolio and commercialisation activities after closing a $2.5m series B financing. The round was led by Great Pacific Capital - the company's managing partner Dave Gross will become a director of BioQ, as part of the financing. Santa Barbara, California-based BioQ offers a series of home test kits for a number of chronic diseases including diabetes, cardiovascular and kidney diseases, colorectal and prostate cancers, thyroid disorders and osteoporosis. The test samples are then mailed to a central lab and users are able to access their results and relevant health information through an online BioQ account.